RAISE Act
Latest action · May 3, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 30, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Renal Anemia Innovation Support and Expansion Act or the RAISE Act
This bill allows coverage of prescription vitamin and mineral products under the Medicare prescription drug benefit if the products are administered orally and are used to treat iron deficiency anemia in individuals who have chronic kidney disease.
Cosponsors 6
Members who signed on, in the order they did. Signatures ran from Apr 30, 2021 to Jul 29, 2021; 3 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NC | G. K. Butterfield | Original | Apr 30, 2021 |
| R-IN | Larry Bucshon | Original | Apr 30, 2021 |
| R-OK | Markwayne Mullin | Original | Apr 30, 2021 |
| R-TX | Dan Crenshaw | Jul 22, 2021 | |
| R-NE | Adrian Smith | Jul 27, 2021 | |
| R-MO | Billy Long | Jul 29, 2021 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 30, 2021 |
| Health Subcommittee | Referred May 3, 2021 | |
| House | Ways and Means Committee | Referred Apr 30, 2021 |
| Social Security Subcommittee | Referred Apr 30, 2021 | |
| Health Subcommittee | Referred Apr 30, 2021 |
Actions 5
Everything that happened, newest first.
- May 3, 2021Referred to the Subcommittee on Health.
- Apr 30, 2021Introduced in House
- Apr 30, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Apr 30, 2021Referred to the Subcommittee on Social Security.
- Apr 30, 2021Referred to the Subcommittee on Health.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 75, April 30, 2021, page H2135.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 8177 | RAISE Act | Reintroduction of | Sep 4, 2020 |
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to remove from the list of drugs excluded from coverage under the Medicare prescription drug program prescription oral vitamins and mineral products indicated for the treatment of iron deficiency anemia in individuals with chronic kidney disease.
- Short Title(s) as Introduced
- RAISE Act
- Renal Anemia Innovation Support and Expansion Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Apr 30, 2021Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.